Key result
Ionomycin increases tissue factor procoagulant activity >100-fold via a calmodulin-dependent mechanism.
Tissue factor (TF) procoagulant activity (PCA) on the surface of intact HL-60 cells is encrypted. This latent TF PCA was activated by exposing the cells to ionomycin, a calcium ionophore. Within seconds an increase in TF PCA of greater than 100-fold was observed. The ionomycin effect was blocked by pretreating the cells with calmidazolium, a calmodulin inhibitor. Changes in TF structure and function, coincident with the ionophore-induced increase in TF PCA, were identified. TF-factor VIIa complexes formed on both untreated and ionophore-treated cells, but pseudosubstrate inhibitors only bound to TF-factor VIIa on the ionophore-treated cells. TF PCA was inhibited by reacting cells with sulfosuccinimidyl-6-(biotinamido)hexanoate, and the rate of this reaction increased twofold after cells were exposed to ionomycin. When proteins on the surface of untreated cells, expressing minimal TF PCA, were cross-linked with 3-3'-dithiobis(sulfosuccinimidylpropionate), cross-linked TF dimers were produced. TF cross-linking was prevented by first treating the cells with ionomycin. These results suggest a mechanism for the ionomycin-induced increase in TF PCA. TF activation appears to be a calmodulin-dependent process, which exposes an essential macromolecular substrate binding site on TF, possibly as the result of a change in TF quaternary structure.
No takes yet. Share an insight, caveat, or question.
Bach et al. (1997) studied this question. Ionomycin vs. Untreated cells was evaluated on Tissue factor (TF) procoagulant activity (PCA) (>100-fold increase). Ionomycin exposure in HL-60 cells increased tissue factor procoagulant activity by greater than 100-fold, a calmodulin-dependent process that exposes a macromolecular substrate binding site.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Blood